Investing.com – Denmark equities were higher at the close on Thursday, as gains in the Real Estate, Healthcare and Consumer Services sectors propelled shares higher.
At the close in Copenhagen, the OMX Copenhagen 20 added 0.58%.
The biggest gainers of the session on the OMX Copenhagen 20 were Genmab (CO:GEN), which rose 3.44% or 38.0 points to trade at 1142.0 at the close. Novo Nordisk A/S B (CO:NOVOb) added 1.56% or 4.3 points to end at 279.3 and Danske Bank A/S (CO:DANSKE) was up 1.29% or 2.7 points to 212.4 in late trade.
Biggest losers included Jyske Bank A/S (CO:JYSK), which lost 4.34% or 14.7 points to trade at 324.0 in late trade. Novozymes A/S B (CO:NZYMb) declined 2.99% or 7.6 points to end at 246.3 and DSV (CO:DSV) shed 1.80% or 6.0 points to 326.8.
Advancing stocks outnumbered falling ones by 87 to 54 and 17 ended unchanged on the Copenhagen Stock Exchange.
In commodities trading, Crude oil for December delivery was up 1.59% or 0.78 to $49.96 a barrel. Meanwhile, Brent oil for delivery in December rose 1.68% or 0.84 to hit $50.82 a barrel, while the December Gold contract rose 0.22% or 2.75 to trade at $1269.35 a troy ounce.
USD/DKK was up 0.13% to 6.8286, while EUR/DKK fell 0.02% to 7.4375.
The US Dollar Index was up 0.36% at 98.94.